Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 81 Pages
Report ld: 4612946
Request Sample
Customized Report
NGAL ELISA Kit Market Size(US$)

CAGR 2025-2031
10.2%
Market Size,2031
USD 143
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for NGAL ELISA Kit was valued at US$ 73 million in the year 2024 and is projected to reach a revised size of US$ 143 million by 2031, growing at a CAGR of 10.2% during the forecast period.
The NGAL(Neutrophil Gelatinase-Associated Lipocalin) Kit is mainly used to quantitatively determine the NGAL content in human blood (including whole blood, serum, plasma) or urine, which is helpful in assisting the diagnosis of renal function damage in clinical practice. According to different detection methods and uses, NGAL test kits can be divided into various types, such as ELISA, immunochromatography and others. This report mainly focuses on NGAL ELISA kit market.
North American market for NGAL ELISA Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for NGAL ELISA Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of NGAL ELISA Kit include Immunodiagnostics, DiaPharma, Thermo Fisher Scientific, Wondfo Biotech, BioPorto, Hycult Biotech, LAB MARK, EasyDiagnosis, Aoruida Biology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for NGAL ELISA Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGAL ELISA Kit.
The NGAL ELISA Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NGAL ELISA Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NGAL ELISA Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Immunodiagnostics
DiaPharma
Thermo Fisher Scientific
Wondfo Biotech
BioPorto
Hycult Biotech
LAB MARK
EasyDiagnosis
Aoruida Biology
Segment by Type
Human NGAL ELISA Kit
Rat NGAL ELISA Kit
Mouse NGAL ELISA Kit
Others
Segment by Application
Clinical
Scientific Research
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NGAL ELISA Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NGAL ELISA Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 NGAL ELISA Kit Market Overview
1.1 Product Definition
1.2 NGAL ELISA Kit by Type
1.2.1 Global NGAL ELISA Kit Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human NGAL ELISA Kit
1.2.3 Rat NGAL ELISA Kit
1.2.4 Mouse NGAL ELISA Kit
1.2.5 Others
1.3 NGAL ELISA Kit by Application
1.3.1 Global NGAL ELISA Kit Market Value by Application (2024 VS 2031)
1.3.2 Clinical
1.3.3 Scientific Research
1.4 Global NGAL ELISA Kit Market Size Estimates and Forecasts
1.4.1 Global NGAL ELISA Kit Revenue 2020-2031
1.4.2 Global NGAL ELISA Kit Sales 2020-2031
1.4.3 Global NGAL ELISA Kit Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 NGAL ELISA Kit Market Competition by Manufacturers
2.1 Global NGAL ELISA Kit Sales Market Share by Manufacturers (2020-2025)
2.2 Global NGAL ELISA Kit Revenue Market Share by Manufacturers (2020-2025)
2.3 Global NGAL ELISA Kit Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of NGAL ELISA Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of NGAL ELISA Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NGAL ELISA Kit, Product Type & Application
2.7 Global Key Manufacturers of NGAL ELISA Kit, Date of Enter into This Industry
2.8 Global NGAL ELISA Kit Market Competitive Situation and Trends
2.8.1 Global NGAL ELISA Kit Market Concentration Rate
2.8.2 The Global 5 and 10 Largest NGAL ELISA Kit Players Market Share by Revenue
2.8.3 Global NGAL ELISA Kit Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global NGAL ELISA Kit Market Scenario by Region
3.1 Global NGAL ELISA Kit Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global NGAL ELISA Kit Sales by Region: 2020-2031
3.2.1 Global NGAL ELISA Kit Sales by Region: 2020-2025
3.2.2 Global NGAL ELISA Kit Sales by Region: 2026-2031
3.3 Global NGAL ELISA Kit Revenue by Region: 2020-2031
3.3.1 Global NGAL ELISA Kit Revenue by Region: 2020-2025
3.3.2 Global NGAL ELISA Kit Revenue by Region: 2026-2031
3.4 North America NGAL ELISA Kit Market Facts & Figures by Country
3.4.1 North America NGAL ELISA Kit Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America NGAL ELISA Kit Sales by Country (2020-2031)
3.4.3 North America NGAL ELISA Kit Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe NGAL ELISA Kit Market Facts & Figures by Country
3.5.1 Europe NGAL ELISA Kit Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe NGAL ELISA Kit Sales by Country (2020-2031)
3.5.3 Europe NGAL ELISA Kit Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NGAL ELISA Kit Market Facts & Figures by Region
3.6.1 Asia Pacific NGAL ELISA Kit Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific NGAL ELISA Kit Sales by Region (2020-2031)
3.6.3 Asia Pacific NGAL ELISA Kit Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NGAL ELISA Kit Market Facts & Figures by Country
3.7.1 Latin America NGAL ELISA Kit Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America NGAL ELISA Kit Sales by Country (2020-2031)
3.7.3 Latin America NGAL ELISA Kit Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa NGAL ELISA Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa NGAL ELISA Kit Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa NGAL ELISA Kit Sales by Country (2020-2031)
3.8.3 Middle East and Africa NGAL ELISA Kit Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NGAL ELISA Kit Sales by Type (2020-2031)
4.1.1 Global NGAL ELISA Kit Sales by Type (2020-2025)
4.1.2 Global NGAL ELISA Kit Sales by Type (2026-2031)
4.1.3 Global NGAL ELISA Kit Sales Market Share by Type (2020-2031)
4.2 Global NGAL ELISA Kit Revenue by Type (2020-2031)
4.2.1 Global NGAL ELISA Kit Revenue by Type (2020-2025)
4.2.2 Global NGAL ELISA Kit Revenue by Type (2026-2031)
4.2.3 Global NGAL ELISA Kit Revenue Market Share by Type (2020-2031)
4.3 Global NGAL ELISA Kit Price by Type (2020-2031)
5 Segment by Application
5.1 Global NGAL ELISA Kit Sales by Application (2020-2031)
5.1.1 Global NGAL ELISA Kit Sales by Application (2020-2025)
5.1.2 Global NGAL ELISA Kit Sales by Application (2026-2031)
5.1.3 Global NGAL ELISA Kit Sales Market Share by Application (2020-2031)
5.2 Global NGAL ELISA Kit Revenue by Application (2020-2031)
5.2.1 Global NGAL ELISA Kit Revenue by Application (2020-2025)
5.2.2 Global NGAL ELISA Kit Revenue by Application (2026-2031)
5.2.3 Global NGAL ELISA Kit Revenue Market Share by Application (2020-2031)
5.3 Global NGAL ELISA Kit Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Immunodiagnostics
6.1.1 Immunodiagnostics Company Information
6.1.2 Immunodiagnostics Description and Business Overview
6.1.3 Immunodiagnostics NGAL ELISA Kit Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Immunodiagnostics NGAL ELISA Kit Product Portfolio
6.1.5 Immunodiagnostics Recent Developments/Updates
6.2 DiaPharma
6.2.1 DiaPharma Company Information
6.2.2 DiaPharma Description and Business Overview
6.2.3 DiaPharma NGAL ELISA Kit Sales, Revenue and Gross Margin (2020-2025)
6.2.4 DiaPharma NGAL ELISA Kit Product Portfolio
6.2.5 DiaPharma Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific NGAL ELISA Kit Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Thermo Fisher Scientific NGAL ELISA Kit Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 Wondfo Biotech
6.4.1 Wondfo Biotech Company Information
6.4.2 Wondfo Biotech Description and Business Overview
6.4.3 Wondfo Biotech NGAL ELISA Kit Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Wondfo Biotech NGAL ELISA Kit Product Portfolio
6.4.5 Wondfo Biotech Recent Developments/Updates
6.5 BioPorto
6.5.1 BioPorto Company Information
6.5.2 BioPorto Description and Business Overview
6.5.3 BioPorto NGAL ELISA Kit Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioPorto NGAL ELISA Kit Product Portfolio
6.5.5 BioPorto Recent Developments/Updates
6.6 Hycult Biotech
6.6.1 Hycult Biotech Company Information
6.6.2 Hycult Biotech Description and Business Overview
6.6.3 Hycult Biotech NGAL ELISA Kit Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hycult Biotech NGAL ELISA Kit Product Portfolio
6.6.5 Hycult Biotech Recent Developments/Updates
6.7 LAB MARK
6.7.1 LAB MARK Company Information
6.7.2 LAB MARK Description and Business Overview
6.7.3 LAB MARK NGAL ELISA Kit Sales, Revenue and Gross Margin (2020-2025)
6.7.4 LAB MARK NGAL ELISA Kit Product Portfolio
6.7.5 LAB MARK Recent Developments/Updates
6.8 EasyDiagnosis
6.8.1 EasyDiagnosis Company Information
6.8.2 EasyDiagnosis Description and Business Overview
6.8.3 EasyDiagnosis NGAL ELISA Kit Sales, Revenue and Gross Margin (2020-2025)
6.8.4 EasyDiagnosis NGAL ELISA Kit Product Portfolio
6.8.5 EasyDiagnosis Recent Developments/Updates
6.9 Aoruida Biology
6.9.1 Aoruida Biology Company Information
6.9.2 Aoruida Biology Description and Business Overview
6.9.3 Aoruida Biology NGAL ELISA Kit Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aoruida Biology NGAL ELISA Kit Product Portfolio
6.9.5 Aoruida Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NGAL ELISA Kit Industry Chain Analysis
7.2 NGAL ELISA Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NGAL ELISA Kit Production Mode & Process Analysis
7.4 NGAL ELISA Kit Sales and Marketing
7.4.1 NGAL ELISA Kit Sales Channels
7.4.2 NGAL ELISA Kit Distributors
7.5 NGAL ELISA Kit Customer Analysis
8 NGAL ELISA Kit Market Dynamics
8.1 NGAL ELISA Kit Industry Trends
8.2 NGAL ELISA Kit Market Drivers
8.3 NGAL ELISA Kit Market Challenges
8.4 NGAL ELISA Kit Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global NGAL ELISA Kit market is projected to grow from US$ 79.7 million in 2025 to US$ 156 million by 2032, at a CAGR of 10.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 145
USD 4900.00
(Single User License)
The global NGAL ELISA Kit market size was US$ 79.7 million in 2025 and is forecast to reach a readjusted size of US$ 156 million by 2032 with a CAGR of 10.2% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 79
USD 4250.00
(Single User License)
The global NGAL ELISA Kit market was valued at US$ 79.7 million in 2025 and is anticipated to reach US$ 156 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 116
USD 2900.00
(Single User License)
The global market for NGAL ELISA Kit was estimated to be worth US$ 79.7 million in 2025 and is projected to reach US$ 156 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 104
USD 3950.00
(Single User License)
The global NGAL ELISA Kit market size was US$ 73 million in 2024 and is forecast to a readjusted size of US$ 143 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 77
USD 4250.00
(Single User License)
The global NGAL ELISA Kit market is projected to grow from US$ 73 million in 2024 to US$ 143 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 134
USD 4900.00
(Single User License)
The global market for NGAL ELISA Kit was estimated to be worth US$ 73 million in 2024 and is forecast to a readjusted size of US$ 143 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 109
USD 3950.00
(Single User License)
The global NGAL ELISA Kit market is projected to grow from US$ 73 million in 2024 to US$ 131 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period.
Published Date: 2024-11-15
Pages: 129
USD 4900.00
(Single User License)
The global NGAL ELISA Kit revenue was US$ 67 million in 2023 and is forecast to a readjusted size of US$ 131 million by 2030 with a CAGR of 10.2% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 106
USD 4350.00
(Single User License)
The global market for NGAL ELISA Kit was estimated to be worth US$ 67 million in 2023 and is forecast to a readjusted size of US$ 131 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030.
Published Date: 2024-11-15
Pages: 109
USD 3950.00
(Single User License)
The global NGAL ELISA Kit market is projected to grow from US$ 79.7 million in 2025 to US$ 156 million by 2032, at a CAGR of 10.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 145
The global NGAL ELISA Kit market size was US$ 79.7 million in 2025 and is forecast to reach a readjusted size of US$ 156 million by 2032 with a CAGR of 10.2% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 79
The global NGAL ELISA Kit market was valued at US$ 79.7 million in 2025 and is anticipated to reach US$ 156 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 116
The global market for NGAL ELISA Kit was estimated to be worth US$ 79.7 million in 2025 and is projected to reach US$ 156 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 104
The global NGAL ELISA Kit market size was US$ 73 million in 2024 and is forecast to a readjusted size of US$ 143 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 77
The global NGAL ELISA Kit market is projected to grow from US$ 73 million in 2024 to US$ 143 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 134
The global market for NGAL ELISA Kit was estimated to be worth US$ 73 million in 2024 and is forecast to a readjusted size of US$ 143 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 109
The global NGAL ELISA Kit market is projected to grow from US$ 73 million in 2024 to US$ 131 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period.
Published: 2024-11-15
Pages: 129
The global NGAL ELISA Kit revenue was US$ 67 million in 2023 and is forecast to a readjusted size of US$ 131 million by 2030 with a CAGR of 10.2% during the review period (2024-2030).
Published: 2024-11-15
Pages: 106
The global market for NGAL ELISA Kit was estimated to be worth US$ 67 million in 2023 and is forecast to a readjusted size of US$ 131 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030.
Published: 2024-11-15
Pages: 109
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now